by David Wallace
Patients are Asking - MPN Expert Dr. Ghaith Abu-Zeinah discusses Ropeginterferon (BESREMi), new Treatment for Polycythemia Vera
Episode 3 of 3
Ropeginterferon / BESREMi was recently approved by the FDA to treat polycythemia vera. Should I switch from Pegasys to the new FDA approved interferon? How might BESREMi change the treatment paradigm for low-risk PV or PV in general?
Stay tuned as there will be a Part 2 video continuing this important discussion on Ropeg.
Dr. Ghaith Abu-Zeinah, Assistant Professor at Weill Cornell Medical College, Silver MPN Center is our MPN specialist answering these questions and more.
David Wallace, PV Reporter, is your host and patient advocate.
Try our new Clinical Trial Finder to search for new treatments and medical approaches for your myelofibrosis (MF), polycythemia vera (PV) or essential thrombocythemia (ET). It's free and no personal information is required.